AccScience Publishing / ARNM / Online First / DOI: 10.36922/arnm.4212
Submit to ARNM
Cite this article
4
Download
51
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
REVIEW ARTICLE

Expert consensus on the utilization of three-dimensional-printed templates for interstitial brachytherapy with iodine-125 seeds in the treatment of recurrent head and neck cancer

Qiman Han1† ,  Bin Qiu1† ,  Yi Chen1 ,  Zhe Ji1 ,  Yuliang Jiang1 ,  Suqing Tian1 ,  Kaixian Zhang2 ,  Ruoyu Wang3 ,  Zhe Wang3 ,  Junjie Wang1*
Show Less
1 Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
2 Department of Oncology, Tengzhou Central People’s Hospital, Zaozhuang, Shandong, China
3 Department of Medical Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China
ARNM 2024, 2(4), 4212 https://doi.org/10.36922/arnm.4212
Submitted: 11 July 2024 | Accepted: 25 September 2024 | Published: 2 January 2025
© 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

Head and neck cancer (HNC) encompasses a range of malignancies that originate from the upper aerodigestive tract. Despite employing a multimodal treatment approach, the recurrence rate for HNC remains high with limited treatment options. One effective treatment method for HNC is interstitial brachytherapy with radioactive seeds, which delivers high localized doses of radiation while minimizing damage to surrounding healthy tissues. The integration of three-dimensional-printed templates (3D-PT) with computed tomography (CT)-guided techniques enhances the precision and control of radioactive seed implantation. This approach enhances treatment accuracy and efficacy, making it a valuable option in the management of HNC and other malignancies. Several factors, such as the specific target site, puncture trajectory, and radiation dosage distribution, can influence the efficacy and safety of seed implantation. At present, there is a lack of comprehensive reports detailing the clinical and technical processes and standards related to 3D-PT-assisted CT-guided particle implantation therapy for recurrent HNC. This consensus aims to address this gap by focusing on the application of 3D-PTs for interstitial brachytherapy using iodine-125 seeds in the treatment of recurrent HNC.

Keywords
3D-printing template
Iodine-125 seeds
Radioactive seed implantation
Brachytherapy
Recurrent head and neck cancer
Funding
None.
Conflict of interest
Junjie Wang is the Editor-in-Chief, while Kaixian Zhang, Ruoyu Wang and Zhe Wang are the Editorial Board Members of this journal and Guest Editors for this special issue, but were not in any way involved in the editorial and peer-review process conducted for this paper, directly or indirectly. Separately, other authors declared that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
References
  1. Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. Lancet. 2021;398(10318):2289-2299. doi: 10.1016/S0140-6736(21)01550-6

 

  1. Vered M, Wright JM. Update from the 5th Edition of the World Health Organization classification of head and neck tumors: Odontogenic and maxillofacial bone tumours. Head Neck Pathol. 2022;16(1):63-75. doi: 10.1007/s12105-021-01404-7

 

  1. Tallari RV, Singh OP, Yogi V, Yadav S. Five versus ten fractions per week radiotherapy in locally advanced head and neck cancer. J Cancer Res Ther. 2017;13(2):224-229. doi: 10.4103/0973-1482.199785

 

  1. Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association, Thyroid Group of Chinese Society of Endocrinology of Chinese Medical Association. Zhonghua Yan Ke Za Zhi. 2022;58(9):646-668. doi: 10.3760/cma.j.cn112142-20220421-00201

 

  1. Mohamed A, Twardy B, Zordok MA, et al. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis. Head Neck. 2019;41(5): 1490-1498. doi: 10.1002/hed.25379.

 

  1. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92. doi: 10.1038/s41572-020-00224-3

 

  1. Ruffin AT, Li H, Vujanovic L, Zandberg DP, Ferris RL, Bruno TC. Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nat Rev Cancer. 2023;23(3):173-188. doi: 10.1038/s41568-022-00531-9

 

  1. Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16(11):669-683. doi: 10.1038/s41571-019-0227-z

 

  1. Davis BJ, Horwitz EM, Lee WR, et al. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy. 2012;11(1):6-19. doi: 10.1016/j.brachy.2011.07.005

 

  1. Chen Y, Jiang Y, Ji Z, et al. Dosimetry, efficacy, and safety of three-dimensional printing noncoplanar template-assisted and CT-guided-125I seed implantation for recurrent retroperitoneal lymphatic metastasis after external beam radiotherapy. Brachytherapy. 2020;19(3):380-388. doi: 10.1016/j.brachy.2020.02.009

 

  1. Wang J, Chai S, Wang R, et al. Expert consensus on computed tomography-assisted three-dimensional-printed coplanar template guidance for interstitial permanent radioactive 125I seed implantation therapy. J Cancer Res Ther. 2019;15(7):1430-1434. doi: 10.4103/jcrt.JCRT_434_19

 

  1. Jiang YL, Ji Z, Tian SQ, et al. CT-guidance interstitial Iodine-125 seed brachytherapy as a salvage therapy for recurrent head and neck carcinoma. Zhonghua Yi Xue Za Zhi. 2018;98:3686-3691. doi: 10.3760/cma.j.issn.0376-2491.2018.45.011

 

  1. Luo YJ, Liu ZL, Ye PC, et al. Safety and efficacy of intraoperative iodine-125 seed implantation brachytherapy for rectal cancer patients: A retrospective clinical research. J Gastroenterol Hepatol. 2016;31(6):1076-1084. doi: 10.1111/jgh.13261

 

  1. Huang M, Lin Q, Wang H, et al. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: A retrospective matched cohort study. Eur Radiol. 2016;26(10):3428-3436. doi: 10.1007/s00330-015-4198-x

 

  1. Yang M, Fang Z, Yan Z, et al. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: A two-arm, randomised clinical trial [published correction appears in J Cancer Res Clin Oncol. 2014 Apr;140(4):687-688]. J Cancer Res Clin Oncol. 2014;140(2):211-219. doi: 10.1007/s00432-013-1568-0

 

  1. Sun H, Zhang M, Liu R, Liu Y, Hou Y, Wu C. Endovascular implantation of 125I seed combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. Future Oncol. 2018;14(12):1165-1176. doi: 10.2217/fon-2017-0354

 

  1. Mo Z, Zhang T, Zhang Y, et al. Feasibility and clinical value of CT-guided 125I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure. Eur Radiol. 2018;28(3):1194-1203. doi: 10.1007/s00330-017-5036-0

 

  1. Qu A, Jiang P, Sun H, et al. Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy. J Gynecol Oncol. 2019;30(1):e9. doi: 10.3802/jgo.2019.30.e9

 

  1. Tong L, Liu P, Huo B, Guo Z, Ni H. CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy. Onco Targets Ther. 2017;10:4081-4088. doi: 10.2147/OTT.S139571

 

  1. Xue H, Qiu B, Wang H, et al. Stereotactic ablative brachytherapy: Recent advances in optimization of radiobiological cancer therapy. Cancers (Basel). 2021;13(14):3493. doi: 10.3390/cancers13143493

 

  1. Suppiah S, Chang WL, Hassan HA, et al. Systematic review on the accuracy of positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging in the management of ovarian cancer: Is functional information really needed? World J Nucl Med. 2017;16(3):176-185. doi: 10.4103/wjnm.WJNM_31_17

 

  1. Ji Z, Jiang Y, Tian S, et al. The effectiveness and prognostic factors of CT-guided radioactive I-125 seed implantation for the treatment of recurrent head and neck cancer after external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2019;103(3):638-645. doi: 10.1016/j.ijrobp.2018.10.034

 

  1. Chen Y, Jiang Y, Ji Z, et al. Efficacy and safety of CT-guided 125I seed implantation as a salvage treatment for locally recurrent head and neck soft tissue sarcoma after surgery and external beam radiotherapy: A 12-year study at a single institution. Brachytherapy. 2020;19(1):81-89. doi: 10.1016/j.brachy.2019.09.006

 

  1. Jiang Y, Ji Z, Guo F, et al. Side effects of CT-guided implantation of 125I seeds for recurrent malignant tumors of the head and neck assisted by 3D printing non Co-planar template. Radiat Oncol. 2018;13(1):18. doi: 10.1186/s13014-018-0959-4

 

  1. Qiu B, Jiang Y, Ji Z, et al. The accuracy of individualized 3D-printing template-assisted I 125 radioactive seed implantation for recurrent/metastatic head and neck cancer. Front Oncol. 2021;11:664996. doi: 10.3389/fonc.2021.664996

 

  1. Chargari C, Deutsch E, Blanchard P, et al. Brachytherapy: An overview for clinicians. CA Cancer J Clin. 2019;69(5): 386-401. doi: 10.3322/caac.21578

 

  1. Hodapp N. Der ICRU-Report 83: Verordnung, Dokumentation und Kommunikation der fluenzmodulierten Photonenstrahlentherapie (IMRT) The ICRU Report 83: Prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188(1):97-99. doi: 10.1007/s00066-011-0015-x

 

  1. Mahé MA, Barillot I, Chauvet B. Recommandations en radiothérapie externe et curiethérapie (Recorad): 2(e) édition Guidelines for external radiotherapy and brachytherapy: 2nd edition. Cancer Radiother. 2016;20 Suppl: S4-S7. doi: 10.1016/j.canrad.2016.07.014

 

  1. Marsico M, Gabbani T, Lunardi S, Galli A, Biagini MR, Annese V. Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles. Arab J Gastroenterol. 2017;18(2):83-86. doi: 10.1016/j.ajg.2017.05.007

 

  1. Kovács G, Martinez-Monge R, Budrukkar A, et al. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update- Improvement by cross sectional imaging based treatment planning and stepping source technology. Radiother Oncol. 2017;122(2):248-254. doi: 10.1016/j.radonc.2016.10.008

 

  1. Takácsi-Nagy Z, Martínez-Mongue R, Mazeron JJ, Anker CJ, Harrison LB. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies. Brachytherapy. 2017;16(1):44-58. doi: 10.1016/j.brachy.2016.07.005

 

  1. Jiang P, Liu C, Wang J, Yang R, Jiang Y, Tian S. Computed tomography (CT)-guided interstitial permanent implantation of (125) I seeds for refractory chest wall metastasis or recurrence. Technol Cancer Res Treat. 2015;14(1):11-18. doi: 10.7785/tcrt.2012.500402

 

  1. Lin L, Wang J, Jiang Y, et al. Interstitial 125I seed implantation for cervical lymph node recurrence after multimodal treatment of thoracic esophageal squamous cell carcinoma. Technol Cancer Res Treat. 2015;14(2):201-207. doi: 10.7785/tcrt.2012.500409

 

  1. Pappas IP, Ryan P, Cossmann P, Kowal J, Borgeson B, Caversaccio M. Improved targeting device and computer navigation for accurate placement of brachytherapy needles. Med Phys. 2005;32(6):1796-1801.doi: 10.1118/1.1901363

 

  1. Ji Z, Jiang Y, Guo F, et al. Dosimetry verification of radioactive seed implantation for malignant tumors assisted by 3D printing individual templates and CT guidance. Appl Radiat Isot. 2017;124:68-74. doi: 10.1016/j.apradiso.2016.12.009

 

  1. Ji Z, Sun H, Jiang Y, et al. Comparative study for CT-guided 125I seed implantation assisted by 3D printing coplanar and non-coplanar template in peripheral lung cancer. J Contemp Brachytherapy. 2019;11(2):169-173. doi: 10.5114/jcb.2019.84503

 

  1. Rembowska AME, Cook M, Hoskin PJ, Mahdevan A. The stepping source dosimetry system as an extension of the manchester system. Radiother Oncol. 1996;39(39):25-25. doi: 10.1016/0167-8140(96)87899-6

 

  1. Huang MW, Zhang JG, Zheng L, Liu SM, Yu GY. Accuracy evaluation of a 3D-printed individual template for needle guidance in head and neck brachytherapy. J Radiat Res. 2016;57(6):662-667. doi: 10.1093/jrr/rrw033

 

  1. Zhang HT, Di XM, Yu HM, et al. Dose comparison between pre and post operation of 125I seeds implantation guided by 3D print template. Zhonghua Yi Xue Za Zhi. 2016;96(9):712-715. doi: 10.3760/cma.j.issn.0376-2491.2016.09.010

 

  1. Liang Y, Wang Z, Zhang H, et al. Three-dimensional-printed individual template-guided 125I seed implantation for the cervical lymph node metastasis: A dosimetric and security study. J Cancer Res Ther. 2018;14(1):30-35. doi: 10.4103/jcrt.JCRT_619_17

 

  1. Sun HT, Jiang YL, Ji Z, et al. 3D printing non-coplanar template-assisted 125-iodine seed implantation for thorax movement tumor: Individual template design method. Zhonghua Yi Xue Za Zhi. 2019;99(47):3699-3702. doi: 10.3760/cma.j.issn.0376-2491.2019.47.005

 

  1. Hongtao Z, Xuemin D, Huimin Y, et al. Dosimetry study of three-dimensional print template-guided precision 125I seed implantation. J Cancer Res Ther. 2016;12(Supplement):C159-C165. doi: 10.4103/0973-1482.200607

 

  1. Li L, Yang J, Li X, et al. (125)I seed permanent implantation as a palliative treatment for stage III and IV hypopharyngeal carcinoma. Clin Exp Otorhinolaryngol. 2016;9(3):185-191. doi: 10.21053/ceo.2015.00213

 

  1. Jiang Y, Zhen P, Dai J, et al. Long-term safety and efficacy of CT-guided I 125 radioactive seed implantation as a salvage therapy for recurrent head and neck squamous carcinoma: A multicenter retrospective study. Front Oncol. 2021;11:645077. doi: 10.3389/fonc.2021.645077

 

  1. Zhang Y, Liang Y, Liu Z, Zhang H, Gao Z, Wang J. Efficacy of radioactive 125I seed implantation in treating inoperable or refused operation head and neck cancers. J Cancer Res Ther. 2024;20(2):642-650. doi: 10.4103/jcrt.jcrt_1891_23

 

  1. Li Y, Jiang Y, Wang J. Safety and efficacy of CT-guided radioactive iodine-125 seed implantation as a salvage treatment for recurrent head and neck cancer after two or more courses of radiotherapy. Radiat Oncol. 2023;18(1):73. doi: 10.1186/s13014-023-02254-z

 

  1. Jiang YL, Meng N, Wang JJ, et al. CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers. Radiat Oncol. 2010;5:68. doi: 10.1186/1748-717X-5-68
Next article in this issue
Share
Back to top
Advances in Radiotherapy & Nuclear Medicine, Electronic ISSN: 2972-4392 Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept